Share This Page
Bulk Pharmaceutical API Sources for TROXYCA ER
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for TROXYCA ER
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Starshine Chemical | ⤷ Get Started Free | 2023-05-5H02339 | ⤷ Get Started Free |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for: TROXYCA ER
Introduction
TROXYCA ER is an extended-release formulation combining oxycodone hydrochloride and acetaminophen, used primarily for managing severe pain in opioid-tolerant patients. As with all opioid formulations, the quality, purity, and security of the active pharmaceutical ingredients (APIs)—oxycodone and acetaminophen—are critical for efficacy, safety, and regulatory compliance. Understanding the sources of bulk APIs for TROXYCA ER is essential for pharmaceutical manufacturers, distributors, and regulatory bodies to ensure product integrity, supply chain reliability, and compliance with international standards.
Overview of API Requirements for TROXYCA ER
Manufacturing TROXYCA ER involves sourcing high-purity APIs that meet stringent pharmacopoeial standards such as USP (United States Pharmacopeia), EP (European Pharmacopoeia), or BP (British Pharmacopoeia). The APIs must comply with Good Manufacturing Practices (GMP), be traceable, and possess validated analytical profiles to prevent adulteration or contamination.
Key considerations include:
- API source verification and batch certifications
- Stability and bioavailability profiles
- Compatibility with formulation and extended-release mechanisms
- Regulatory approvals for API sourcing
Major API Sources for Oxycodone Hydrochloride
Global Production Hubs
Oxycodone, a semi-synthetic opioid derived from thebaine, is predominantly manufactured in countries with strict regulatory oversight and established pharmaceutical industries.
Leading Suppliers:
- United States – Major pharmaceutical companies and licensed API manufacturers operate under strict FDA compliance. Companies like Purdue Pharma, Endo Pharmaceuticals, and Mallinckrodt possess extensive production facilities, though direct API suppliers are often contract manufacturers or licensed third-party suppliers [1].
- India – Recognized as a key global API producer, India has numerous approved API manufacturers offering oxycodone hydrochloride complying with GMP standards. Notable companies include Sun Pharma, Dr. Reddy’s Labs, and Cadila Healthcare, which maintain validated sources for high-quality APIs [2].
- China – A significant raw material and API supplier for opioids, with several government-licensed facilities producing oxycodone. Strict regulatory oversight has increased in recent years, with companies such as Huarun XinHua and North China Pharmaceutical Group being noteworthy [3].
Regulatory & Supply Chain Considerations:
- International scrutiny over opioid production has increased due to misuse concerns, leading to tighter export controls in China and India.
- API sourcing from licensed and audited manufacturers is critical for licensing, audits, and ensuring supply continuity.
Major API Suppliers for Acetaminophen
Global Production Hubs
Acetaminophen (paracetamol) is widely produced across multiple regions, given its broad use and established manufacturing processes.
Leading Suppliers:
- India – Dominates the global market, with companies like Aarti Drugs, Micro Labs, and Jubilant Life Sciences producing pharmaceutical-grade acetaminophen in large volumes that meet international pharmacopoeial standards [4].
- China – Major raw material supplier for acetaminophen, with extensive manufacturing capacity and a broad export portfolio. Regulatory rigor varies, but top-tier manufacturers hold GMP certifications [5].
- United States & Europe – While primarily consumers of acetaminophen APIs, domestic manufacturers include companies like Akers Biosciences and others that reliably supply pharmaceutical-grade APIs compliant with USP and other standards.
Supply Chain & Quality Assurance:
- The API must pass stringent quality controls, including testing for residual solvents, heavy metals, microbial contamination, and potency.
- Due to widespread manufacturing, sourcing from reputable suppliers with validated GMP certificates is standard.
API Sourcing Strategies and Validation
Dual Sourcing & Redundancy
Manufacturers of TROXYCA ER typically adopt dual sourcing strategies to mitigate supply disruptions. Multiple approved suppliers—globally dispersed—are engaged for both oxycodone HCl and acetaminophen, with strict audit and qualification processes to ensure compliance with regulatory standards.
Quality Assurance & Regulatory Compliance
- Suppliers must furnish Certificates of Analysis (CoA), Certificates of Compliance, and site GMP certifications.
- Regular on-site audits and testing ensure API quality and consistency.
- Sourcing from WHO-GMP, EU-GMP, or PIC/S-certified facilities is standard practice.
Tracking & Traceability
Advanced serialization and supply chain management systems enhance traceability, crucial for controlled substances like oxycodone. These systems help verify API origins, transportation conditions, and batch integrity.
Legal and Regulatory Considerations
Given the controlled status of oxycodone in many jurisdictions, API exporters face stringent licensure and export controls, especially from countries like China and India. International treaties, such as the Single Convention on Narcotic Drugs (1961), impose strict regulations on the production and transfer of opioids [6].
Manufacturers sourcing APIs for TROXYCA ER must conduct due diligence to ensure legal compliance, including licensing, import/export permits, and adherence to local and international narcotics laws.
Emerging Trends in API Sourcing for Pain Management Drugs
- API Quality and Synthetic Advances: Technologies such as continuous manufacturing are optimizing API quality and reducing costs.
- Supply Chain Security: Blockchain and digital track-and-trace systems are increasingly implemented to prevent diversion and counterfeit APIs.
- Regulatory Harmonization: International agencies, including the FDA and EMA, promote harmonized standards, simplifying the approval process for API manufacturers and buyers.
Summary of Key Sources
| API | Principal Producing Countries | Notable Manufacturers | Certifications/Standards |
|---|---|---|---|
| Oxycodone Hydrochloride | USA, India, China | Purdue Pharma, Sun Pharma, North China Pharm. | GMP, OSHA, DEA licenses, Drug Master Files (DMFs) |
| Acetaminophen | India, China, USA | Aarti Drugs, Jubilant, Akers Biosciences | USP, EP, GMP, ISO certifications |
Conclusion
The supply of high-quality APIs for TROXYCA ER hinges on sourcing from reputable, GMP-certified manufacturers with validated supply chains. Predominantly, India and China serve as core sources for oxycodone hydrochloride and acetaminophen, respectively. Ensuring strict quality standards, legal compliance, and supply chain security are pivotal for pharmaceutical companies manufacturing TROXYCA ER.
Key Takeaways
- Reliable sourcing of oxycodone and acetaminophen APIs is essential for TROXYCA ER's safety and efficacy.
- India and China dominate the global API production landscape, offering high-volume, GMP-compliant supplies.
- Due diligence, including certification verification and supply chain audits, safeguards against contamination and legal issues.
- Strategic dual sourcing reduces risk and ensures continuity in global supply chains amid regulatory tightening.
- Advancements in manufacturing and traceability technologies enhance the security and integrity of API sourcing in pain management medications.
FAQs
Q1: How do regulatory agencies verify the quality of API suppliers for opioids like oxycodone?
A1: Agencies conduct audits, review Certificates of Analysis, and inspect manufacturing facilities to ensure compliance with GMP, DEA licensing, and international standards such as PIC/S and ISO certifications.
Q2: Are there international differences in API sourcing regulations for controlled substances?
A2: Yes, countries enforce varying legal controls and licenses for opioid APIs, with stricter controls in jurisdictions like the US and EU, impacting export and import procedures.
Q3: What risks are associated with sourcing APIs from less regulated manufacturers?
A3: Risks include contaminated or adulterated APIs, inconsistent potency, regulatory non-compliance, and potential supply disruptions.
Q4: How does supply chain security influence API sourcing decisions?
A4: Secure supply chains with validated traceability reduce the risk of diversion, counterfeiting, and contamination, ensuring product safety and regulatory compliance.
Q5: Are there any alternatives to traditional sourcing for APIs used in TROXYCA ER?
A5: Yes, pharmaceutical companies explore synthetic or biosynthetic pathways, local manufacturing, and technological innovations to reduce dependence on traditional sources and improve supply resilience.
References
[1] U.S. Food and Drug Administration. "Drug Master Files." FDA.gov. 2022.
[2] Indian Pharmaceutical Alliance. "API Manufacturing & Regulatory Landscape." IPA.in. 2022.
[3] Chinese National Medical Products Administration (NMPA). "Opioid API Regulations." NMPA.gov.cn. 2022.
[4] IndiaBrand Equity Foundation (IBEF). "Pharmaceutical Industry in India." IBef.org. 2022.
[5] European Medicines Agency. "Acetaminophen (Paracetamol) Manufacturing Standards." EMA.eu. 2022.
[6] International Narcotics Control Board. "Implementation of the Single Convention." INCB.org. 2022.
More… ↓
